Lv7
5000 积分 2022-09-27 加入
The Pathologic Response Evaluation and Detection in Circulating Tumor-DNA Study: Ultrasensitive Circulating Tumor-DNA Assessment of Breast Cancer Minimal Residual Disease
6天前
已完结
Advancements in liquid biopsy for breast Cancer: Molecular biomarkers and clinical applications
6天前
已完结
Response to crizotinib in advanced ALK-rearranged non-small cell lung cancers with different ALK-fusion variants
8天前
已完结
ALK inhibitors in the treatment of advanced NSCLC
16天前
已完结
Circulating tumor DNA analysis guiding adjuvant therapy in stage II colon cancer: 5-year outcomes of the randomized DYNAMIC trial
1个月前
已完结
Early Postoperative Minimal Residual Disease Detection with MAESTRO Is Associated with Recurrence and Worse Survival in Patients with Head and Neck Cancer
1个月前
已完结
Circulating Tumor DNA Dynamics as Prognostic Markers in Locally Advanced and Metastatic Esophageal Squamous Cell Carcinoma
1个月前
已完结
Dynamic ctDNA Monitoring Guides Early Treatment Intensification in Locally Advanced Rectal Cancer Undergoing Neoadjuvant Chemotherapy
2个月前
已完结
Ultrasensitive ctDNA monitoring reveals early predictors of immunotherapy response in advanced cancer
2个月前
已完结
Cerebrospinal fluid circulating tumor DNA profiling for risk stratification and matched treatment of central nervous system metastases
2个月前
已完结
皖公网安备34019202002308
